Business
Clinuvel (ASX:CUV) share price falls despite positive update
The Clinuvel Pharmaceuticals Limited (ASX: CUV) share price is tumbling in early morning trade. This comes despite releasing an update to the market. At the time of writing, the biopharmaceutical company’s shares are swapping hands for $27.99, down 2.3%.
What did Clinuvel announce?
The Clinuvel share price is being weighed down by investors despite the company’s positive announcement.
According to this morning’s release, Clinuvel advised that it has now expanded its DNA repair program. The clinical trials will now evaluate afamelanotide in skin cells which have been damaged by ultraviolet (UV) and sun exposure. Patients suffering from rare…
-
General18 hours agoBali scooter crash victim Keanu Neilsen’s surgery could cost more than $100,000
-
Noosa News22 hours agoOprah Winfrey Is Getting Chatting in Australia and NZ in 2025 on Her First Down Under Tour in a Decade
-
Noosa News12 hours agoTerminal evacuated at Brisbane Airport, significant delays expected
-
Noosa News15 hours agoFormer Channel Nine reporter Benjamin McCormack facing dozens of child abuse material charges in Brisbane